G S S Pharma Private Limited, a active private limited company, was established on 07 August 2015 in Whitefield, Karnataka, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U51102KA2015PTC082095. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 23 professional, Its leadership includes Kongarahalli Ganga Reddy Nagaraja (Director), Geethanjali Chandrareddy (Director), Babukumar Kavitha (Director). It holds ₹5.17 Cr open charges and ₹8.31 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Officeno:201, 2Nd Floor ,Unispace Business Centre Plot No 128-P2 , Adjacent To Ginger Hote, L Epipzone, Whitefield, Karnataka, 560066.
U51102KA2015PTC082095
082095
07 August 2015
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into G S S Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kongarahalli Ganga Reddy Nagaraja | Director | 07 Aug 2015 | Current |
| Geethanjali Chandrareddy | Director | 07 Aug 2015 | Current |
| Babukumar Kavitha | Director | 01 Jan 2025 | Current |
| Shivanna Hassan Sridhar | Director | 01 Jan 2025 | Current |
| Vishal Venugopal | Director | 01 Jan 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
G S S Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 48.19% increase. The company also saw a slight improvement in profitability, with a 4.24% increase in profit. The company's net worth Soared by an impressive increase of 45.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, G S S Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹51,717,997.00
₹8,306,400.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jan 2025 | Hdfc Bank Limited | ₹1.72 M | Open |
| 25 Apr 2024 | Others | ₹3.00 Cr | Open |
| 14 Oct 2020 | Others | ₹2.00 Cr | Open |
| 20 Mar 2019 | Hdfc Bank Limited | ₹4.81 M | Satisfied |
| 25 Oct 2018 | Others | ₹3.50 M | Satisfied |
Explore comprehensive loan charge details -
G S S Pharma has a workforce of 23 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of G S S Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped G S S Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.72 M with Charge ID 101096001 was registered on 29 Jan 2025. was documented.
Babukumar Kavitha was appointed as a Director was appointed as a Director on 01 Jan 2025 & has been associated with this company since 11 months 25 days . was recorded as a recent event.
Shivanna Hassan Sridhar was appointed as a Director was appointed as a Director on 01 Jan 2025 & has been associated with this company since 11 months 25 days . was recorded as a recent event.
Progress on Vishal Venugopal was appointed as a Director was appointed as a Director on 01 Jan 2025 & has been associated with this company since 11 months 25 days . was documented.
The activity G S S Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Others amounted to Rs. 30.00 M with Charge ID 100920530 was registered on 25 Apr 2024. was recorded as a recent event.
The CIN of G S S Pharma Private Limited is U51102KA2015PTC082095.
G S S Pharma Private Limited is headquartered at Officeno:201, 2Nd Floor ,Unispace Business Centre Plot No 128-P2 , Adjacent To Ginger Hote, L Epipzone, Whitefield, Karnataka, 560066.
G S S Pharma Private Limited was incorporated on 07 August 2015.
The current directors of G S S Pharma Private Limited are
The primary industry of G S S Pharma Private Limited is Hospital And Medical Care.
G S S Pharma Private Limited is unlisted.
The authorized capital of G S S Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of G S S Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX